![Gwenn Hansen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 3 M $ al 30/09/2026
Gwenn M.
Hansen is Chief Scientific Officer at Nurix Therapeutics, Inc. since 2020, with employment at the company starting in 2015.
Formerly, served as Associate Professor at Baylor College of Medicine.
Education includes undergraduate studies at Gustavus Adolphus College and a doctorate from the University of Tennessee.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
NURIX THERAPEUTICS, INC. 0,11 % | 15/10/2026 | 117.227 ( 0,11 % ) | 3 M $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| NURIX THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 01/07/2019 |
| Empresas | Cargo | Fin |
|---|---|---|
Baylor College of Medicine
 Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Nurix Therapeutics, Inc.
 Nurix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a a clinical stage biopharmaceutical company that discovers, develops and commercializes oral, small molecule therapies for the treatment of cancer & immune disorders | Health Technology |
Gustavus Adolphus College
 Gustavus Adolphus College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Tennessee
 University of Tennessee Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baylor College of Medicine
Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
